481 ECOG 4593: Phase II hyperfractionated accelerated radiotherapy (HART) for non small cell lung cancer (NSCLC): Early results and RT quality assurance (QA) Article

Mehta, M, Tannehill, S, Martin, L et al. (1997). 481 ECOG 4593: Phase II hyperfractionated accelerated radiotherapy (HART) for non small cell lung cancer (NSCLC): Early results and RT quality assurance (QA) . 18 123. 10.1016/s0169-5002(97)89861-3

cited authors

  • Mehta, M; Tannehill, S; Martin, L; Wagner, H; Johnson, D

authors

publication date

  • August 1, 1997

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Cancer
  • Lung
  • Lung Cancer
  • Radiation Oncology
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • Elsevier

start page

  • 123

volume

  • 18